High-caffeine energy drinks like Celsius combined with Adderall and nicotine spike anxiety; Tums offers temporary relief but carries long-term stomach/kidney risks with inconsistent results.
ADHD patients on stimulants like Adderall experience heightened anxiety from daily high-caffeine energy drinks like Celsius combined with nicotine, while seeking ways to reduce anxiety without losing medication effectiveness.
Taking Tums with Adderall
Bro, the celsius is making your anxiety worse.
commentBro, the celsius is making your anxiety worse. I used to be an energy drink a day person too, but when I started taking meds, I had to cut down (didn’t want my ticker to crap out). Try and replace the celsius with a redbull or something with less caffeine, then maybe a soda, then slowly phase all caffeine out if you can. It’s hard. Redbull has 110mgs, and a smaller can with only 80mgs.
Working adults with ADHD on Adderall who consume Celsius/energy drinks and nicotine daily for focus and energy but suffer rebound anxiety.
Strong repetition on Celsius as anxiety trigger and Tums as risky workaround; multiple users report relief from removing energy drinks.
Specifically formulated and tested for Adderall + nicotine users, unlike general nootropics or generic anxiety apps.
Personalized daily supplement stack + simple mobile tracker that provides anxiety-mitigating support compatible with stimulants, replacing risky Tums and high-caffeine drinks.
Users already spend on Celsius ($3+/day) and experiment with Tums; signals show strong desire for reliable anxiety relief that preserves medication effectiveness, with explicit complaints about unsustainable workarounds.
“Lower anxiety on Adderall without losing focus or risking daily Tums.”
Personalized daily supplement stack + simple mobile tracker that provides anxiety-mitigating support compatible with stimulants, replacing risky Tums and high-caffeine drinks.
Reddit communities (r/ADHD, r/adderall, r/Nootropics) and targeted Facebook ADHD groups with free 7-day starter kits
Individual biochemistry differences may limit consistent anxiety reduction across users on varying Adderall doses.
Claims involving interaction with prescription stimulants require careful disclaimers; users may hesitate without doctor endorsement.
Paid ads in ADHD communities are competitive and trust-building takes time.
Users may discontinue once they stabilize routines or consult doctors for official protocols.
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoThis idea scores in the upper-middle range of opportunities surfaced by MonetScope, with a validation sub-score of 8/10 against 3 independently sourced evidence signals. A "promising" rating usually indicates a real pain has been detected and discussed in the open, but the pipeline did not find enough signal to flag it as urgent or high-frequency. These opportunities can still produce excellent businesses — they often correspond to "boring" problems that established players have ignored — but the founder should expect a longer customer-development cycle to confirm willingness to pay.
It sits at the intersection of "adhd", "automation", "consultants", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. Opportunities in this category typically reward founders who can describe the pain in the user's own language — both because that's the basis of effective marketing, and because it's the strongest signal that the founder has done the upfront listening. The MonetScope pipeline surfaces this category alongside other other signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most other opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.
